<span item_type="fundamental" item_id="ceaa064b1a8b8ef330e90f60363b591d" counter_id="ST/US/LEXXW" env="prod"></span><span item_type="announcement" item_id="538106814961095425" env="prod"></span><p>營收：截至 2025 財年 Q3，公佈值為 53.19 萬美元。</p><p>每股收益：截至 2025 財年 Q3，公佈值為 -0.53 美元。</p><p></p><h3>財務指標按部門劃分</h3><h4>收入</h4><ul><li><strong>IP Licensing</strong>: 收入為 $522,000。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>B2B 產品</strong>: 收入為 $9,923。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>合計</strong>: 總收入為 $531,923。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>營運費用</h4><ul><li><strong>研發費用</strong>: 研發費用為 $6,356,637。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>總營運費用</strong>: 總營運費用為 $9,721,343。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>其他收入（損失）</h4><ul><li><strong>其他收入（損失）</strong>: 為 - $22,066。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>現金流</h4><ul><li><strong>經營活動現金流</strong>: 經營活動使用的現金為 - $7,807,889。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>投資活動現金流</strong>: 投資活動使用的現金為 - $85,141。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>融資活動現金流</strong>: 融資活動提供的現金為 $6,046,163。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>未來展望和策略</h4><ul><li><strong>核心業務重點</strong>: 公司計劃繼續推進 DehydraTECH 技術在 GLP-1/GIP 藥物和 CBD 治療糖尿病和減肥方面的研發。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li><li><strong>非核心業務</strong>: 公司可能會通過與第三方的許可協議、合作、夥伴關係、聯盟營銷、分銷或許可安排來增加資本資源。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>經營虧損</h4><ul><li><strong>淨虧損</strong>: 淨虧損為 - $9,214,206。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul><h4>資產總計</h4><ul><li><strong>總資產</strong>: 總資產為 $6,741,366。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1348362/000164033425001195/lxrp_10q.htm"></span></li></ul>

LEXARIA BIOSCIENCE CORP C/WTS 14/01/2026 (TO PUR COM)｜10-Q：2025 財年 Q3 營收 53.19 萬美元